CELEX: 62009TJ0492
Language: en
Date: 2012-06-07
Title: Judgment of the General Court (Eighth Chamber) of 7 June 2012. # Meda Pharma GmbH & Co. KG v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM). # Community trade mark - Opposition proceedings - International registration designating the European Community - Word mark ALLERNIL - Application for Community word mark ALLERNIL - Earlier national word mark ALLERGODIL - Relative ground of refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 - Grounds - Article 75 of Regulation No 207/2009. # Joined cases T-492/09 and T-147/10.

Judgment of the General Court (Eighth Chamber) of 7 June 2012 —Meda Pharma v OHIM — Nycomed (ALLERNIL)(Joined Cases T-492/09 and T-147/10)
      Community trade mark — Opposition proceedings — International registration designating the European Community — Word mark ALLERNIL — Application for Community word mark ALLERNIL — Earlier national word mark ALLERGODIL — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Grounds — Article 75 of Regulation No 207/2009
      Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 30, 52)
      Re:
      
         
               Two actions brought against two decisions of the Fourth Board of Appeal of OHIM of 29 September 2009 (Cases R 1386/2007-4
                  and R 697/2007-4), relating to opposition proceedings between Meda Pharma GmbH & Co. KG and Nycomed GmbH.
               
            Operative part
      The Court:
      
         
                  1.
               
               
                  
               
               
                  	Dismisses the actions;
               
            
         
                  2.
               
               
                  
               
               
                  	Orders Meda Pharma GmbH & Co. KG to pay the costs incurred in Joined Cases T-492/09 and T-147/10.